微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -0.54% | -169.23% | -1180% | 114/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.05% | -89.36% | -16.67% | 112/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.06% | -88.46% | 101.28% | 116/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -4.7% | -1144.44% | -702.56% | 117/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 0.78% | 8.33% | 65.96% | 111/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.47% | 14.63% | -9.62% | 110/158 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.52% | 13.04% | 15.56% | 110/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 0.45% | 102.95% | -37.5% | 106/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 0.72% | -73.33% | 75.61% | 109/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.41% | -73.38% | -10.87% | 110/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.46% | -39.47% | 103.02% | 107/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -15.24% | -1151.03% | -664.44% | 133/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 2.7% | -13.74% | 75.32% | 96/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.54% | 69.23% | 102.63% | 104/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.76% | 105.41% | -47.59% | 102/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 1.45% | -43.14% | -53.67% | 101/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 3.13% | 8.68% | 243.96% | 83/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.91% | -58.64% | 145.95% | 101/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.37% | -75.66% | -85.49% | 78/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.55% | -46.99% | -11.46% | 104/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.88% | -46.27% | 30.91% | 87/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.2% | -42.11% | 44.74% | 83/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.52% | -20.83% | -68.4% | 69/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 4.81% | -46.56% | -10.26% | 89/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.36% | -47.76% | 41.05% | 64/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.8% | -48.02% | 97.92% | 59/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.92% | -53.62% | -78.67% | 56/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 9% | -57.18% | -12.28% | 56/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 10.26% | -35.88% | 40.36% | 26/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 7.31% | -35.59% | 76.57% | 26/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 4.14% | 5.08% | -80.3% | 12/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 21.02% | -26.12% | 31.38% | 24/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 16% | -29.92% | 40.97% | 10/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 11.35% | -28.8% | 188.07% | 9/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.94% | -25.94% | -86.15% | 19/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 28.45% | 45.52% | 24.62% | 11/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 22.83% | 64.72% | 43.22% | 4/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 15.94% | 59.56% | 199.62% | 4/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 5.32% | 23.15% | -72.79% | 11/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | 19.55% | 26.21% | 41.05% | 26/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 13.86% | 33.65% | 38.74% | 11/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 9.99% | 49.1% | 131.25% | 8/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 4.32% | 50.52% | -72.11% | 11/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |